Impact of clinical decision support on empirical antibiotic prescribing for children with community-acquired pneumonia

J Paediatr Child Health. 2019 Mar;55(3):305-311. doi: 10.1111/jpc.14191. Epub 2018 Aug 30.

Abstract

Aim: To assess the impact of a computerised clinical decision support system (CDSS) on antibiotic use in hospitalised children with a presumptive diagnosis of uncomplicated community-acquired pneumonia (CAP).

Methods: Codes associated with lower respiratory tract infection were used to identify cases of presumed uncomplicated CAP requiring admission to a tertiary paediatric hospital. Random sampling of the periods between 1 October 2010 and 30 September 2012 (pre-CDSS) and 1 October 2012 and 30 September 2014 (post-CDSS) determined the sequence of case assessment by two independent investigators. Initial antibiotic therapy, associated CDSS approvals and documented signs of clinical deterioration prior to antibiotic decision-making were recorded.

Results: Statistically significant differences between cases pre- and post-CDSS implementation were minimal. High fever was observed in 57.5% (77/134) cases pre-CDSS and 45.8% (49/107) cases post-CDSS (P = 0.07). Supplemental oxygen was used in 30.6% pre-CDSS and 54.2% post-CDSS cases (P < 0.001). Narrow-spectrum penicillins were prescribed most often, with no statistically significant change post-CDSS implementation (81.3% pre-CDSS, 77.6% post-CDSS, P = 0.47). Macrolides were used consistently throughout the study period (53.7% pre-CDSS, 61.7% post-CDSS; P = 0.21).

Conclusion: CDSS implementation did not reduce already low rates of broad-spectrum antibiotic use for uncomplicated CAP.

Keywords: anti-infective agent; child; community-acquired infection; physician; practice guidelines as topic; practice pattern.

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Community-Acquired Infections / drug therapy*
  • Decision Support Systems, Clinical*
  • Drug Prescriptions*
  • Female
  • Humans
  • Infant
  • Male
  • Practice Guidelines as Topic

Substances

  • Anti-Bacterial Agents